Renal thrombotic microangiopathy and pulmonary arterial hypertension in a patient with late-onset cobalamin C deficiency

• Published in: Clinical kidney journal 2018-06, Vol.11 (3), p.310-314
• Main Authors: Petropoulos, Taylor E, Ramirez, Maria Erika, Granton, John, Licht, Christoph, John, Rohan, Moayedi, Yasbanoo, Morel, Chantal F, McQuillan, Rory F
• Format: Article
• Language: English
• Subjects: Chronic kidney failure; Homocysteine; Physiological aspects; Pulmonary hypertension; Rare Diseases
• ISSN: 2048-8505; 2048-8513
• DOI: 10.1093/ckj/sfx119

ABSTRACT Cobalamin C (cblC) deficiency is the most commonly inherited inborn error of vitamin B12 metabolism. It is characterized by multisystem involvement with severe neurological, hematological, renal and cardiopulmonary manifestations. Disease is most commonly diagnosed early in the first decade of life. We report a case of a 20-year-old woman who developed severe pulmonary arterial hypertension while under nephrologic follow-up for chronic kidney disease. She had initially presented at 14 years of age with visual disturbance and acute renal failure and been diagnosed with thrombotic thrombocytopenic purpura on the basis of kidney biopsy findings of thrombotic microangiopathy and compatible ADAMTS13 (a disentegrin and metalloproteinase with a thrombospondin type 1 motif member 13). When cblC deficiency was eventually diagnosed, remarkable improvement in cardiopulmonary function was evident upon initiation of treatment. This case highlights the importance of a timely diagnosis and initiation of treatment for cblC deficiency. Clinical diagnosis may be challenged by asynchronous organ symptom presentation and by misleading laboratory tests, in this case: an initial low ADAMTS13. A simple test of plasma homocysteine level should be encouraged in cases of thrombotic microangiopathy and/or pulmonary artery hypertension.